Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IDH1 pseudogene 1 (IDH1P1) is a non-functional gene with sequence similarity to the IDH1 enzyme gene. Unlike IDH1, which encodes a cytosolic and peroxisomal enzyme involved in NADPH generation and implicated in cancer biology[1][7][8], IDH1P1 does not encode an active protein and is not involved in metabolic pathways or disease. It is sometimes mistakenly listed or searched as a biological or therapeutic target, but it should not be considered for drug development, biomarker analysis, or molecular classification. Clarification: The true target of interest in cancer and metabolic research is isocitrate dehydrogenase 1 (IDH1), which is an enzyme involved in the citric acid cycle and is frequently mutated in diffuse gliomas and other tumors[1][5][7]. IDH1P1 should not be confused with IDH1. If your intent is to obtain structured information on the actual enzyme target, search for "Isocitrate dehydrogenase 1 (IDH1)" instead.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on IDH1 pseudogene 1 (IDH1P1).